Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Management of adult Ph-positive acute lymphoblastic leukemia.

Hematology. American Society of Hematology. Education Program - 1 Jan 2015

Chiaretti Sabina, Foà Robin

Abstract excerpt

Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) has been regarded for decades as the ALL subgroup with the worse outcome. It represents the most frequent genetic subtype of adult ALL, and increases progressively with age. The introduction of tyrosine kinase inhibitors (TKIs) has enabled to obtain complete hematologic remissions (CHRs) in virtually all patients, including the elderly, to improve...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Fusion Proteins, bcr-abl
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm, Residual

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Remission Induction

Share to Stem Cell Transplantation

Share to Transplantation, Homologous

Source

Identifiers

PMID: 26637750
DOI: 10.1182/asheducation-2015.1.406

Genes

SCT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Management of adult Ph-positive acute lymphoblastic leukemia.PMID 26637750Read ↗

How has the management of Ph+ acute lymphoblastic leukemia (ALL) changed over the years.Semantic proximity Read ↗

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in AdultsSemantic proximity Read ↗

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.Semantic proximity Read ↗

Current paradigms in the management of P hiladelphia chromosome positive acute lymphoblastic leukemia in adultsSemantic proximity Read ↗

Ph+ ALL: new approaches for upfront therapySemantic proximity Read ↗

Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).Semantic proximity Read ↗

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity Read ↗

Advances in the Genetics and Therapy of Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Advances in the Genetics and Therapy of Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular LandscapeSemantic proximity Read ↗

Philadelphia Chromosome–Positive Acute Lymphocytic Leukemia: A New Era of ChallengesSemantic proximity Read ↗

Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.